Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in BioMarin Pharmaceutical Inc
Today
Create an eToro account to buy BMRN stock on a secure, user-friendly, multi-asset trading platform.
Buy BioMarin Pharmaceutical Inc
Buy BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc BMRN
Buy BMRN
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
104.5
Based on analysts who covered BMRN

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

BioMarin Pharmaceutical Inc News

Stocks-BMRN-BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc BMRN

$70.60.06(0.09%)(1D)
• Nasdaq • in USD

BMRN Stock Price Chart

‎9.05‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset stable trend

The BioMarin Pharmaceutical Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The BioMarin Pharmaceutical Inc share price today is $70.6, reflecting a ‎0.09‎% change over the last 24 hours and ‎-0.3‎% over the past week. The current market capitalization of BMRN is 13.47B with an average volume in the last three months of 1.53M. The stock has a P/E ratio of 32.1 and a dividend yield of 0%. With the stock’s beta sitting at 0.67
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$13.47B
Day’s Range
i
Shows the high and low prices of the day.
68.36 - 73.37
52W Range
i
Shows the high and low prices of the last year.
60.54 - 99.36
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.53M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
32.1
Revenue
i
The total income generated by this company’s goods and services last year.
$2.84B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$70.6
EPS
i
A company’s total earnings divided by the number of shares it has issued.
2.2
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.67
What Is BioMarin Pharmaceutical Inc?
BioMarin Pharmaceutical Inc is a leading global biotechnology company headquartered in San Rafael, California, with locations in the United States, South America, Asia, and Europe. Established in 1997, BioMarin is engaged in the development and commercialisation of therapies for rare genetic diseases in children and adults, with its main focus on enzyme replacement therapies and various types of gene therapy.

The firm has successfully brought to market various treatments for rare genetic diseases such as achondroplasia, phenylketonuria, morquio A syndrome, and CLN2 disease, with more products at various research stages in the firm’s pipeline. BioMarin owns and operates its own manufacturing facilities, allowing for a high degree of quality control and efficiency in its manufacturing process. These facilities include three current Good Manufacturing Practices (cGMP) plants in Novato, California, and Shanbally, Ireland.

The firm has around 3,000 employees worldwide, and Forbes named BioMarin one of America’s Best Midsize Employers in 2019. The firm owns various subsidiary companies, including Prosensa, BioMarin Europe Ltd., Zacharon Pharmaceuticals Inc., Glyko Inc., Huxley Pharmaceuticals Inc., and LEAD Therapeutics Inc. The company is listed on the NASDAQ, where it trades under the ticker BMRN.

Add BMRN stock to your eToro watchlist today to get real-time updates on Biomarin share price movements.
Buy BMRN

How can I buy BioMarin Pharmaceutical Inc stocks?

To purchase BioMarin Pharmaceutical Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the BioMarin Pharmaceutical Inc (BMRN) page and place an order to buy BioMarin Pharmaceutical Inc.
Buy BMRN
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy BioMarin Pharmaceutical Inc
Invest in BioMarin Pharmaceutical Inc
Today
Create an eToro account to buy BMRN stock on a secure, user-friendly, multi-asset trading platform.
Buy BMRN

FAQ

The current price of BMRN is $70.6.
The average price target for BioMarin Pharmaceutical Inc is $70.6. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for BioMarin Pharmaceutical Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of BioMarin Pharmaceutical Inc is $13.47B
Daily Movers
Explore the biggest stocks movers on the market.
Buy BMRN
Scroll to top